Paid Clinical Trials in Bellflower, CA
As of August 2026, 43 paid clinical trials are recruiting in Bellflower, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Bellflower offers studies at sites including Kaiser Permanente-Bellflower for conditions such as Major Depressive Disorder, Anatomic Stage IV Breast Cancer AJCC v8, Schizophrenia, Stage IV Lung Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Bellflower
Trials by drug in Bellflower
Filter results
Newly added in Bellflower
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
41 clinical trials
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
A Study of Brenipatide in Adult Participants With Schizophrenia
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
A Study to Evaluate the Effect of KarXT on Urological Safety
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
E-Mindfulness Approaches for Living After Breast Cancer
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Mobile Health for Adherence in Breast Cancer Patients
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Study of ALTO-300 in MDD
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Top Research Study Locations in Bellflower
Researchers run research studies in Bellflower, CA at 12 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Kaiser Permanente-Bellflower | Anatomic Stage IV Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Breast Cancer | 24 |
| Clinical Innovations, Inc. dba CITrials | Schizophrenia, Bipolar Disorder, Bipolar Disorder Type I With Mania | 5 |
| Clinical Innovations Inc | Bipolar Depression, Bipolar Disorder, Bipolar I Disorder | 2 |
| CI Trials | Depressive Disorder, Major | 1 |
| CITrials | Bipolar-I Disorder With Mania or Mania With Mixed Features | 1 |
| CenExel | Bipolar I Disorder | 1 |
| CenExel CIT (Clinical Innovations, Inc) | Major Depressive Disorder | 1 |
| CenExel CIT LA | Schizophrenia Disorders | 1 |
| Cenexel Cit - Bellflower | Major Depressive Disorder | 1 |
| Kaiser Permanente Bellflower Medical Offices | Urothelial Carcinoma | 1 |
| Local Institution - 0040 | Schizophrenia | 1 |
| Southern California Permanente Medical Group | Solid Tumors | 1 |
Active & Upcoming Studies in Bellflower (2026)
Recruiting trials in Bellflower grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (21 active studies)
- Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer · Phase 3 · National Cancer Institute (NCI)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Mental health & behavior (11 active studies)
- Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications · Phase 3 · Minerva Neurosciences
Common conditions studied in Bellflower
- Major Depressive Disorder (5 active studies)
- Anatomic Stage IV Breast Cancer AJCC v8 (3 active studies)
- Schizophrenia (3 active studies)
- Stage IV Lung Cancer AJCC v8 (3 active studies)
- Bipolar Disorder (2 active studies)
- Bipolar I Disorder (2 active studies)
Leading research sponsors in Bellflower
- NRG Oncology
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Bristol-Myers Squibb
- Xenon Pharmaceuticals Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Bellflower?
There are approximately 43 recruiting clinical trials in Bellflower, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Bellflower pay participants?
Most recruiting trials in Bellflower compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Bellflower?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Bellflower?
The most common conditions under active study in Bellflower include Major Depressive Disorder (5), Anatomic Stage IV Breast Cancer AJCC v8 (3), Schizophrenia (3), Stage IV Lung Cancer AJCC v8 (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Bellflower?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Bellflower on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Bellflower?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Bellflower?
Recruiting research sites in Bellflower include Kaiser Permanente-Bellflower, Clinical Innovations, Inc. dba CITrials, Clinical Innovations Inc, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Bellflower right now?
The largest active categories in Bellflower are Cancer & tumors (21), Mental health & behavior (11). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.